José van den Berg
By using WGS, we took a step forward in molecular diagnostics in our department from the analysis of less than 100 genes to approximately 20,000 genes per patient. This provides an enormous amount of valuable information, not only for the patient of today, but also for the patient of the future.
Back to newsMore news
The value of the GENAYA project for patients of the future
The GENAYA project has been extended through 2028. A total of 39 hospitals now participate in the project, which is led by …
Breast cancer awareness month
October is the international breast cancer awareness month. Breast cancer is the second most common type of cancer, and the …
The viral landscape in metastatic solid cancers
Researchers from Norwegian University of Science and Technology and colleagues have recently systematically catalogued the presence of viral DNA (and …
Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer with targeted treatment, be it a registered therapy or part of a research trial.